Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioharvest Sciences Inc C.BHSC

Alternate Symbol(s):  CNVCD

Consumer Defensive Household & Personal Products Biotechnology
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business... see more

Recent & Breaking News (CSE:BHSC)

BioHarvest Sciences (CSE:BHSC) announces $8M private placement

John Ballem  February 21, 2023

BioHarvest Sciences Announces a Private Placement of up to CAD $8M of Convertible Notes to Grow Core Business

Newsfile February 21, 2023

BioHarvest Sciences Collaborating with Yo Murphy and NFL Prospects to Build Awareness of Blood Flow Importance

Newsfile February 16, 2023

BioHarvest Sciences Announces Clinical Study in Patients with Multiple Sclerosis-Related Optic Neuritis

Newsfile February 14, 2023

BioHarvest Sciences Reports 2022 Sales Orders of USD 6.1M Representing 2.6X Increase over 2021

Newsfile February 9, 2023

BioHarvest Sciences Inc. Appoints Dr. George Garibaldi to Its Scientific Board of Advisors

Newsfile January 17, 2023

BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event January 19, 2023, at 2:00 PM E.T.

Newsfile January 11, 2023

Bioharvest Sciences Inc. 2022 CEO Letter to Shareholder Partners

Newsfile December 29, 2022

BioHarvest Sciences Inc. Projects 2023 Revenue to Grow 3.0X-3.5X to a Range of USD $17M-$20M

Newsfile December 15, 2022

Royal Emerald Pharmaceuticals Partners with BioHarvest Sciences to Supply Disruptive Cannabis Solutions to Companies Conducting FDA-Approved Medical Research

Newsfile November 16, 2022

BioHarvest Sciences (CSE:BHSC) closes second tranche of private placement

John Ballem  November 15, 2022

BioHarvest Sciences Inc. Announces Closing of the Second Tranche of Private Placement of Convertible Notes and Expects the Offering to Be Oversubscribed and to Close an Additional Tranche of up to $3 Million by December 15, 2022

Newsfile November 15, 2022

BioHarvest Sciences CEO to Detail Multi-Pronged Cannabis Strategy in North America at Online Webinar, Nov 16 at 2pm ET

Newsfile November 14, 2022

BioHarvest (CSE:BHSC) introduces 1st cannabis breakthrough with major medical & commercial implications

Jonathon Brown October 25, 2022

BioHarvest Introduces its 1st Cannabis Breakthrough Composition with Major Medical and Commercial Implications

Newsfile October 25, 2022

AiAdvertising's Campaign Performance Platform Helps Lift Q3 Sales for BioHarvest Sciences' Resveratrol Superfood Supplement VINIA

Business Wire October 20, 2022

BioHarvest Sciences Inc. Announces Closing of the First Tranche of Private Placement of Convertible Notes

Newsfile October 13, 2022

BioHarvest (CSE:BHSC) announces the oversubscription of its private placement and change in note terms

Azuka Onwuka October 7, 2022

BioHarvest Sciences Inc. Announces the Oversubscription of Private Placement of Convertible Notes and Change in Note Terms.

Newsfile October 7, 2022

BioHarvest (CSE:BHSC) sees record sales in Q3 2022

Jonathon Brown October 3, 2022